News | November 01, 2023
Pfizer posts Q3 loss as Covid-19 revenues shrink
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
Additional premium services in RegXcellence will include access to BASF’s Product Carbon Footprint data and direct downloads of audit reports
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions
The composition of ORAAL is protected by a granted patent in India until November 2033
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Subscribe To Our Newsletter & Stay Updated
